DIVERSIFIED HEALTHCARE TRUST (DHC) Form 8-K — Nov 2, 2026

$DHCForm 8-KItems 2.02, 9.01Filed Nov 2, 2026, 4:36 PM ET0001075415-26-000037Original filing

Diversified Healthcare Trust (Nasdaq: DHC) reported Q3 2026 results showing a sharp operational turnaround: Normalized FFO rose to $0.13 per share from $0.02 a year ago, and same-property cash NOI grew 25.6% year over year to $77.9 million. The SHOP segment was the standout, with same-property NOI up 50.4%, occupancy up 200 basis points to 84.4%, and NOI margins expanding 470 basis points to 15.8%. Leverage improved with net debt to annualized Adjusted EBITDAre falling 2.5x YoY to 8.2x.

Key figures

Revenue: 367670000
Total Debt: 2441401000
Total Assets: 4189406000
Cash Position: 110659000
Total liquidity: $260.7M
Normalized ffo q3: $30.7M / $0.13 per share (vs $0.02 prior year)
Adjusted ebitdare q3: $73.4M, +28.4% YoY
Quarterly distribution: $0.01 per share
Shop noi margin expansion: 470 bps to 15.8%
Shop same property occupancy: 84.4%, +200 bps YoY
Same property cash noi growth: 25.6% YoY
Shop same property noi growth: 50.4% YoY
Medical office life science leasing: ~130,000 sq ft at rents 25.2% above prior, 9.7-yr WALT
Ensign snf lease initial annual rent: $8.0M, 15-year triple net
Net debt to annualized adjusted ebitdare: 8.2x (down 2.5x YoY)
Updated fy2026 adjusted ebitdare guidance: $275.7M-$290.7M (recast)
Updated fy2026 normalized ffo per share guidance: $0.46-$0.52 (recast, from $0.56-$0.62)

AI analysis

Red flags5 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

Upgrade to Pro · $49/mo billed annually

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.